ARTERRA BIOSCIENCE SPA (ARBS.MI) Stock Fundamental Analysis

BIT:ARBS • IT0005386369

3.34 EUR
-0.02 (-0.6%)
Last: Feb 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Taking everything into account, ARBS scores 4 out of 10 in our fundamental rating. ARBS was compared to 0 industry peers in the Unkown industry. ARBS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ARBS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ARBS was profitable.
  • In the past year ARBS had a positive cash flow from operations.
  • In the past 5 years ARBS has always been profitable.
  • Each year in the past 5 years ARBS had a positive operating cash flow.
ARBS.MI Yearly Net Income VS EBIT VS OCF VS FCFARBS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

1.2 Ratios

  • The last Return On Invested Capital (13.11%) for ARBS is above the 3 year average (9.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.59%
ROE 16.33%
ROIC 13.11%
ROA(3y)9.93%
ROA(5y)10.02%
ROE(3y)11.74%
ROE(5y)12.1%
ROIC(3y)9.13%
ROIC(5y)9.66%
ARBS.MI Yearly ROA, ROE, ROICARBS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • In the last couple of years the Profit Margin of ARBS has remained more or less at the same level.
  • ARBS's Operating Margin has been stable in the last couple of years.
  • ARBS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 46.43%
PM (TTM) 42.38%
GM 63.6%
OM growth 3Y0.28%
OM growth 5Y-1.05%
PM growth 3Y3.33%
PM growth 5Y0.25%
GM growth 3Y-2.51%
GM growth 5Y-0.98%
ARBS.MI Yearly Profit, Operating, Gross MarginsARBS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • ARBS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ARBS has about the same amount of shares outstanding.
  • The number of shares outstanding for ARBS has been reduced compared to 5 years ago.
  • ARBS has a better debt/assets ratio than last year.
ARBS.MI Yearly Shares OutstandingARBS.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ARBS.MI Yearly Total Debt VS Total AssetsARBS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • An Altman-Z score of 7.89 indicates that ARBS is not in any danger for bankruptcy at the moment.
  • ARBS has a debt to FCF ratio of 0.30. This is a very positive value and a sign of high solvency as it would only need 0.30 years to pay back of all of its debts.
  • A Debt/Equity ratio of 0.02 indicates that ARBS is not too dependend on debt financing.
  • Although ARBS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.3
Altman-Z 7.89
ROIC/WACC1.42
WACC9.26%
ARBS.MI Yearly LT Debt VS Equity VS FCFARBS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.3 Liquidity

  • ARBS has a Current Ratio of 7.40. This indicates that ARBS is financially healthy and has no problem in meeting its short term obligations.
  • ARBS has a Quick Ratio of 6.31. This indicates that ARBS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 7.4
Quick Ratio 6.31
ARBS.MI Yearly Current Assets VS Current LiabilitesARBS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 37.48% over the past year.
  • The Earnings Per Share has been growing by 10.01% on average over the past years. This is quite good.
  • ARBS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.44%.
  • The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)37.48%
EPS 3Y8.02%
EPS 5Y10.01%
EPS Q2Q%109.79%
Revenue 1Y (TTM)13.44%
Revenue growth 3Y2.94%
Revenue growth 5Y9.02%
Sales Q2Q%14.28%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARBS.MI Yearly Revenue VS EstimatesARBS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.13 indicates a reasonable valuation of ARBS.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, ARBS is valued rather cheaply.
Industry RankSector Rank
PE 11.13
Fwd PE N/A
ARBS.MI Price Earnings VS Forward Price EarningsARBS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 21.45
EV/EBITDA 7.94
ARBS.MI Per share dataARBS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.11
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • ARBS has a Yearly Dividend Yield of 3.94%.
  • ARBS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 3.94%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 44.46% of the earnings are spent on dividend by ARBS. This is a bit on the high side, but may be sustainable.
DP44.46%
EPS Next 2YN/A
EPS Next 3YN/A
ARBS.MI Yearly Income VS Free CF VS DividendARBS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
ARBS.MI Dividend Payout.ARBS.MI Dividend Payout, showing the Payout Ratio.ARBS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ARTERRA BIOSCIENCE SPA

BIT:ARBS (2/4/2026, 7:00:00 PM)

3.34

-0.02 (-0.6%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners46.87%
Ins Owner ChangeN/A
Market Cap22.24M
Revenue(TTM)4.49M
Net Income(TTM)1.90M
Analysts82.86
Price Target3.88 (16.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.94%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP44.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.13
Fwd PE N/A
P/S 4.95
P/FCF 21.45
P/OCF 11.7
P/B 1.91
P/tB 1.91
EV/EBITDA 7.94
EPS(TTM)0.3
EY8.98%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY4.66%
OCF(TTM)0.29
OCFY8.55%
SpS0.67
BVpS1.75
TBVpS1.75
PEG (NY)N/A
PEG (5Y)1.11
Graham Number3.44
Profitability
Industry RankSector Rank
ROA 13.59%
ROE 16.33%
ROCE 16.27%
ROIC 13.11%
ROICexc 17.92%
ROICexgc 17.98%
OM 46.43%
PM (TTM) 42.38%
GM 63.6%
FCFM 23.07%
ROA(3y)9.93%
ROA(5y)10.02%
ROE(3y)11.74%
ROE(5y)12.1%
ROIC(3y)9.13%
ROIC(5y)9.66%
ROICexc(3y)15.47%
ROICexc(5y)17.58%
ROICexgc(3y)15.82%
ROICexgc(5y)18.81%
ROCE(3y)11.33%
ROCE(5y)12.02%
ROICexgc growth 3Y-16.84%
ROICexgc growth 5Y-17%
ROICexc growth 3Y-14.48%
ROICexc growth 5Y-12.8%
OM growth 3Y0.28%
OM growth 5Y-1.05%
PM growth 3Y3.33%
PM growth 5Y0.25%
GM growth 3Y-2.51%
GM growth 5Y-0.98%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.3
Debt/EBITDA 0.11
Cap/Depr 269.44%
Cap/Sales 19.23%
Interest Coverage 250
Cash Conversion 78.96%
Profit Quality 54.44%
Current Ratio 7.4
Quick Ratio 6.31
Altman-Z 7.89
F-Score6
WACC9.26%
ROIC/WACC1.42
Cap/Depr(3y)76.68%
Cap/Depr(5y)90.12%
Cap/Sales(3y)7.07%
Cap/Sales(5y)10.14%
Profit Quality(3y)69.73%
Profit Quality(5y)57.78%
High Growth Momentum
Growth
EPS 1Y (TTM)37.48%
EPS 3Y8.02%
EPS 5Y10.01%
EPS Q2Q%109.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.44%
Revenue growth 3Y2.94%
Revenue growth 5Y9.02%
Sales Q2Q%14.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.77%
EBIT growth 3Y3.23%
EBIT growth 5Y7.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.65%
FCF growth 3Y-20.26%
FCF growth 5Y25.42%
OCF growth 1Y3.72%
OCF growth 3Y-8.67%
OCF growth 5Y-9.31%

ARTERRA BIOSCIENCE SPA / ARBS.MI FAQ

Can you provide the ChartMill fundamental rating for ARTERRA BIOSCIENCE SPA?

ChartMill assigns a fundamental rating of 4 / 10 to ARBS.MI.


What is the valuation status of ARTERRA BIOSCIENCE SPA (ARBS.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to ARTERRA BIOSCIENCE SPA (ARBS.MI). This can be considered as Overvalued.


Can you provide the profitability details for ARTERRA BIOSCIENCE SPA?

ARTERRA BIOSCIENCE SPA (ARBS.MI) has a profitability rating of 3 / 10.


How sustainable is the dividend of ARTERRA BIOSCIENCE SPA (ARBS.MI) stock?

The dividend rating of ARTERRA BIOSCIENCE SPA (ARBS.MI) is 3 / 10 and the dividend payout ratio is 44.46%.